1.
Item | Tissue/cell line | Relationship to immune checkpoints | Function | Ref. |
MiRNAs | ||||
MiR-424 (322) | Ovarian cancer tissue and ovarian cancer cell lines | Anticorrelates with CD80
and PD-L1 |
Low levels of miR-424(322) are associated with chemoresistance | 26 |
MiR-15/16 family | Glioma mouse model | Correlates with PD-1, TIM-3, LAG-3 | Low levels of miR-15a/16 prolongs mice survival | 32 |
MPM tissue and
MPM cell lines |
Anticorrelates with PD-L1 | High PD-L1 is associated with low miR-15/16 levels and short overall survival | 48 | |
MiR-138 | Glioma mouse model | Anticorrelates with PD-1,
CTLA-4 |
High level of miR-138 inhibit tumor progression | 33 |
CRC patient samples and
CRC cell lines |
Anticorrelates with PD-L1 | Low levels of miR-138 are associated with shorter overall survival | 34 | |
MiR-28 | Exhausted T-cells from
mice melanoma |
Anticorrelates with PD-1,
TIM3 and BTLA |
Low levels of miR-28 induces T-cell exhaustion | 35 |
MiR-155 | Mouse T-cells | Anticorrelates with BTLA | Low levels of miR-155 decrease
CD4+ T cell activation |
37 |
Dermal lymphatic
endothelial cells |
Anticorrelates with PD-L1 | MiR-155 is part of a regulatory loop which controls the expression of PD-L1 | 57 | |
MiR-29c and
other 12 miRNAs |
Breast cancer cell lines and tissue from breast cancer patients | Anticorrelates with B7-H3 | High levels of miR-29c associate with a decreased risk of dying from breast cancer | 39 |
MiR-570 | Gastric cancer tissue | Anticorrelates with PD-L1 | The inability of miR-570 to bind the PD-L1 mRNA leads to an aggressive gastric cancer phenotype | 42 |
MiR-34a
(and miR-34 family) |
TCGA lung adenocarcinoma, p53 (R172HΔ)g/+K-ras (LA1/+) mouse model and various
cell lines |
Anticorrelates with PD-L1 | P53 regulates the anti-tumor immunity by overexpressing miR-34, an inhibitor of PD-L1 | 43 |
AML patient samples and leukemia cell lines | Anticorrelates with PD-L1 | High levels of miR-34 decrease T-cell apoptosis | 44 | |
MiR-34a and
MiR-200c |
AML cell lines
and AML mouse model |
Anticorrelates with PD-L1 | High levels of miR-34a and miR-200c leads to increased immune mediated killing of the tumor | 45 |
MiR-197 | NSCLC patient samples and human lung cancer cell lines | Anticorrelates with PD-L1 | Low level of miR-197 predict low survival in NSCLC | 46 |
Oral squamous cell carcinoma | Anticorrelates with PD-L1 | High levels of miR-197 predict poor overall survival | 52 | |
MiR-200 | Lung adenocarcinoma databases, different mouse models and cell models | Anticorrelates with PD-L1 | MiR-200 simultaneously inhibits neoplastic invasion and immunosuppression | 49 |
MiR-20b, miR-21
and miR-130b |
CRC tissue | Correlate with PD-L1 | MiR-20b, miR-21 and miR-130b inhibit PTEN, which is an inhibitor of PD-L1 | 50 |
MiR-574-3p | Spinal chordoma tissue | Anticorrelates with PD-L1 | Low levels of miR-574-3p are associated with worse local recurrence-free survival | 51 |
MiR-25-93-106b
cluster |
Primary pancreatic cancer cells from murine models | Anticorrelates with PD-L1 | The miRNA cluster controls the bone marrow metastasis | 53 |
Continued |